Assuming just 10% of eligible beneficiaries use Wegovy in a given year, and assuming a 50% rebate on the list price, Medicare would incur nearly $3 billion in additional net Part D spending for one year for this one drug alone.KFF also finds that beneficiaries who take Wegovy could face monthly out-of-pocket costs of $325 to $430 if they have to pay a percentage of the drugs $1,300 list price for a months supply
Many people who require weight management also have elevated cholesterol, making the concurrent use of these medicines a logical therapeutic approach
If you experience significant nausea or gastrointestinal discomfort, your provider may extend the interval to five or six weeks before increasing
During your first week on Wegovy, you will not be left in the dark to navigate the side effects and lifestyle adjustments alone
After reviewing comments, the FDA will issue a final determination
Detoxification capacity can also vary between individuals, including differences in glutathione-related enzymes that influence drug handling